4.5 Review

Probiotics and the Treatment of Parkinson's Disease: An Update

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Effects of long-term administration of Multi-Strain Probiotic on circulating levels of BDNF, NGF, IL-6 and mental health in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial

Mehran Rahimlou et al.

Summary: The study found that six months of probiotic supplementation in patients with MS led to significant improvements in mental health parameters, including increased BDNF levels, decreased IL-6 levels, and improved scores on various health questionnaires.

NUTRITIONAL NEUROSCIENCE (2022)

Article Immunology

Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway

Jing Sun et al.

Summary: The study suggests that the probiotic Clostridium butyricum (Cb) has neuroprotective effects on Parkinson's disease (PD) by improving abnormal gut microbiota-gut-brain axis. This intervention could potentially reverse motor deficits, dopaminergic neuron loss, synaptic dysfunction, and microglia activation in PD, providing a new insight into treating PD through gut microbiota modulation.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Article Immunology

The impact of dextran sodium sulphate and probiotic pre-treatment in a murine model of Parkinson's disease

Zach Dwyer et al.

Summary: This study examined the effects of pre-treatment with a probiotic and an inflammatory inducer on PD pathology in a murine model. The probiotic showed no significant effects, while the inflammatory inducer caused marked changes in gut microbiome and increased behavioral and inflammatory outcomes. These findings suggest a potential link between disruption of intestinal integrity and systemic inflammatory events in promoting brain-gut changes relevant to PD.

JOURNAL OF NEUROINFLAMMATION (2021)

Article Neurosciences

Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation

Stefano Romano et al.

Summary: Recent studies have shown significant alterations in the gut microbiome of Parkinson's disease patients compared to healthy individuals, which may result in a pro-inflammatory status and impact the symptoms and pathophysiology of the disease.

NPJ PARKINSONS DISEASE (2021)

Article Biochemistry & Molecular Biology

Oral Administration of Probiotic Bifidobacterium breve Improves Facilitation of Hippocampal Memory Extinction via Restoration of Aberrant Higher Induction of Neuropsin in an MPTP-Induced Mouse Model of Parkinson's Disease

Toshiaki Ishii et al.

Summary: The study showed that oral administration of Bifidobacterium breve strain A1 could reverse the facilitation of hippocampal memory extinction in PD mice, restoring abnormal changes in synaptic plasticity and facilitating fear extinction through regulating neuropsin expression levels.

BIOMEDICINES (2021)

Review Cell Biology

Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms

Omid Reza Tamtaji et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)

Review Pharmacology & Pharmacy

Can Growth Factors Cure Parkinson's Disease?

Yulia A. Sidorova et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2020)

Review Immunology

Gut microbiota in neurodegenerative disorders

Suparna Roy Sarkar et al.

JOURNAL OF NEUROIMMUNOLOGY (2019)

Review Cell Biology

Aquaporin 4: A key player in Parkinson's disease

Omid Reza Tamtaji et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Clinical Neurology

Dysbiosis of gut microbiota in a selected population of Parkinson's patients

Daniele Pietrucci et al.

PARKINSONISM & RELATED DISORDERS (2019)

Article Immunology

Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence

Luca Magistrelli et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Multidisciplinary Sciences

Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease

Sebastiaan P. van Kessel et al.

NATURE COMMUNICATIONS (2019)

Article Clinical Neurology

Increased Oxidative Stress Exacerbates α-Synuclein Aggregation In Vivo

Owen Scudamore et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)

Article Clinical Neurology

Investigation of probiotics in multiple sclerosis

Stephanie K. Tankou et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

Review Biotechnology & Applied Microbiology

Probiotic Species in the Modulation of Gut Microbiota: An Overview

Md. Abul Kalam Azad et al.

BIOMED RESEARCH INTERNATIONAL (2018)

Article Clinical Neurology

Investigation of probiotics in multiple sclerosis

Stephanie K. Tankou et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

Review Neurosciences

Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis

Zexu Wei et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)

Article Biotechnology & Applied Microbiology

Manifestations and Outcomes of Patients with Parkinson's Disease and Serious Infection in the Emergency Department

Chih-Min Su et al.

BIOMED RESEARCH INTERNATIONAL (2018)

Review Clinical Neurology

Gut microbiota: Implications in Parkinson's disease

Arun Parashar et al.

PARKINSONISM & RELATED DISORDERS (2017)

Review Geriatrics & Gerontology

The Role of Microgliain Retinal Neurodegeneration: Alzheimer's Disease, Parkinson,and Glaucoma

Ana I. Ramirez et al.

FRONTIERS IN AGING NEUROSCIENCE (2017)

Review Clinical Neurology

Microbiota and neurodegenerative diseases

Moira Marizzoni et al.

CURRENT OPINION IN NEUROLOGY (2017)

Review Biochemistry & Molecular Biology

Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis

Susan Westfall et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2017)

Article Medicine, Research & Experimental

Analysis of Gut Microbiota in Patients with Parkinson's Disease

V. A. Petrov et al.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2017)

Review Biochemistry & Molecular Biology

The clinical symptoms of Parkinson's disease

Sigurlaug Sveinbjornsdottir

JOURNAL OF NEUROCHEMISTRY (2016)

Article Geriatrics & Gerontology

Nonmotor gastrointestinal disorders in older patients with Parkinson's disease: is there hope?

Doina Georgescu et al.

CLINICAL INTERVENTIONS IN AGING (2016)

Article Immunology

Risk and Safety of Probiotics

Shira Doron et al.

CLINICAL INFECTIOUS DISEASES (2015)

Review Gastroenterology & Hepatology

Brain-gut-microbiota axis in Parkinson's disease

Agata Mulak et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Review Medicine, Research & Experimental

The Role of Oxidative Stress in Neurodegenerative Diseases

Geon Ha Kim et al.

EXPERIMENTAL NEUROBIOLOGY (2015)

Article Biotechnology & Applied Microbiology

Tyramine biosynthesis is transcriptionally induced at low pH and improves the fitness of Enterococcus faecalis in acidic environments

Marta Perez et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2015)

Review Food Science & Technology

Food Omics Validation: Towards Understanding Key Features for Gut Microbiota, Probiotics and Human Health

Maria Lujan Jimenez-Pranteda et al.

FOOD ANALYTICAL METHODS (2015)

Article Clinical Neurology

Gut Microbiota Are Related to Parkinson's Disease and Clinical Phenotype

Filip Scheperjans et al.

MOVEMENT DISORDERS (2015)

Article Biochemistry & Molecular Biology

A Role for the p75 Neurotrophin Receptor in Axonal Degeneration and Apoptosis Induced by Oxidative Stress

Bradley R. Kraemer et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Review Biochemistry & Molecular Biology

Microbiota and neurodevelopmental windows: implications for brain disorders

Yuliya E. Borre et al.

TRENDS IN MOLECULAR MEDICINE (2014)

Article Nutrition & Dietetics

Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease

Masahiko Suzuki et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)

Review Biochemistry & Molecular Biology

Oxidative damage to macromolecules in human Parkinson disease and the rotenone model

Laurie H. Sanders et al.

FREE RADICAL BIOLOGY AND MEDICINE (2013)

Article Neurosciences

Overview of Tyrosine Hydroxylase in Parkinson's Disease

Yanzhen Zhu et al.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2012)

Article Gastroenterology & Hepatology

Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli Strains

Luca Mogna et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)

Review Clinical Neurology

Microglial Activation and Chronic Neurodegeneration

Melinda E. Lull et al.

NEUROTHERAPEUTICS (2010)

Review Clinical Neurology

Parkinson's disease: clinical features and diagnosis

J. Jankovic

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)

Article Biochemistry & Molecular Biology

Silencing α-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells

Dongmei Liu et al.

NEUROCHEMICAL RESEARCH (2008)

Review Neurosciences

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Michelle L. Block et al.

NATURE REVIEWS NEUROSCIENCE (2007)

Review Biochemistry & Molecular Biology

Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease

Yoon Seong Kim et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2006)

Article Pharmacology & Pharmacy

JNK inhibition as a potential strategy in treating Parkinson's disease

WY Wang et al.

DRUG NEWS & PERSPECTIVES (2004)

Article Oncology

Oxidative stress-induced apoptosis is mediated by ERK1/2 phosphorylation

YJ Lee et al.

EXPERIMENTAL CELL RESEARCH (2003)

Article Neurosciences

Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra

DW Howells et al.

EXPERIMENTAL NEUROLOGY (2000)